Jérôme Alexandre
Inserm(FR)Université Paris Cité(FR)Sorbonne Université(FR)Centre de Recherche des Cordeliers(FR)Hôpital Cochin(FR)Assistance Publique – Hôpitaux de Paris(FR)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers, Endometrial and Cervical Cancer Treatments, BRCA gene mutations in cancer
Most-Cited Works
- → Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study(2020)443 cited
- → Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients(2004)309 cited
- → Dimethyl fumarate, a two‐edged drug: Current status and future directions(2019)156 cited
- → Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial(2016)139 cited
- → Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer(2021)127 cited
- → Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial